• SENSEX 73,123.83
    -125.56 (--0.17%)
  • BANKNIFTY 54,287.35
    -638.35 (--1.16%)
  • SBI
    950.75 900.80(%)
  • Tonbo Imaging
    1,209.85 1,209.85(%)
  • Cyient
    1,268.00 1,268.00(%)
  • NSE
    1,640.25 1,640.25(%)
  • Bonfiglioli Tran
    527.40 527.40(%)
  • IndusInd Bank
    831.35 750.45(%)
  • Eternal
    317.50 344.75(%)
  • JSW Energy
    440.25 428.00(%)
  • Voltas
    940.00 940.00(%)
  • Swiggy
    174.90 174.90(%)
  • Persistent Systems
    5,688.80 4,242.65(%)
  • Cupid
    302.45 45.40(%)
  • TCS
    2,624.75 3,336.70(%)
  • Infosys
    1,198.30 1,727.85(%)
  • Havells India
    1,003.65 1,003.65(%)
  • PC Jeweller
    17.08 7.45(%)
  • Bharat Forge
    1,680.45 1,265.00(%)
  • C P C L
    1,529.95 1,677.00(%)
  • Netweb Technol.
    4,238.00 2,942.45(%)
  • Lenskart Solut.
    615.80 355.70(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Venmax Drugs & Pharmaceuticals Ltd Trading

  • Indian Private
  • BSE Code : 6161.0
  • ISIN : INE154G01022
14.48 -1 (-3.40%)
  • As on 25 Oct 2026 (EOD)

  • Today’s Low

    13.52

  • Today’s High

    14.80

  • Open

    13.52

  • Perv Close

    14.99

  • 52W Low

    12.71

  • 52W High

    31.49

Key Indicators

  • P/E(TTM)

    76.21

  • Mar.Cap (₹Cr.)

    20.97

  • Div & Yield %

    0.00

  • Book Value(₹)

    14.37

  • Debt-Equity Ratio

    -3.40

  • AGM Date

    23-Oct-2026

  • EPS

    0.19

  • P/E Ratio

    76.21

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    20.97

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    14.48

  • BV (₹)

    14.40

  • Sales( ₹ in Cr.)

    8.02

  • NP (in Cr.)

    0.25

  • NP Var(%)

    2464.0

  • Div%

    0.0

  • CPS (₹)

    0.20

  • EPS (₹)

    0.20

  • Traded Value (₹ in Lakhs)

    20.97

  • 52 Week High

    31.49

  • 52 Week Low

    12.71

  • Price BSE

    14.0

  • Price NSE

    0.00

  • Market Capital( in Cr.)

    20.97

  • P/C Ratio

    80.40

  • P/E Ratio

    81.70

  • Price Vs.BV

    0.20

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 8.02 0.81 0.00 0.00 0.00 0.17
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 8.02 0.81 0.00 0.00 0.00 0.17
Other Income 0.16 1.05 0.20 0.42 1.98 0.18
Stock Adjustments 0.94 0.06 0.00 0.00 0.00 -0.22
Total Income 9.12 1.92 0.20 0.42 1.98 0.13
EXPENDITURE :            
Raw Materials 8.22 0.85 0.00 0.00 0.00 0.08
Power and Fuel Cost 0.01 0.00 0.00 0.01 0.00 0.00
Employee Cost 0.20 0.04 0.02 0.03 0.01 0.06
Other Manufacturing Expenses 0.00 0.00 0.01 0.00 0.00 0.00
Selling and Administration Expenses 0.16 0.81 0.05 0.10 0.11 0.13
Miscellaneous Expenses 0.25 0.22 0.02 0.04 0.01 0.02
Employee Benefit Expenses 0.20 0.04 0.02 0.03 0.01 0.06
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 8.84 1.92 0.10 0.19 0.13 0.29
Operating Profit 0.28 -0.01 0.09 0.23 1.86 -0.15
Interest 0.00 0.00 0.00 0.00 0.00 0.00
Gross Profit 0.28 -0.01 0.09 0.23 1.86 -0.15
Depreciation 0.00 0.01 0.01 0.01 0.01 0.01
Profit Before Tax 0.28 -0.02 0.08 0.22 1.85 -0.16
Current Tax 0.03 0.00 0.02 0.00 0.00 0.00
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00
Reported Net Profit 0.25 -0.01 0.06 0.23 1.85 -0.16
Extraordinary Items 0.00 0.00 0.00 0.00 0.00 0.00
Adjusted Net Profit 0.25 -0.01 0.06 0.23 1.85 -0.16
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward -5.90 -5.89 -5.95 -6.18 -8.76 -8.59
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down -5.65 -5.90 -5.89 -5.95 -6.91 -8.76
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 0.21 -0.02 0.12 0.43 3.52 -0.31
Earnings Per Share(Adj)-Unit Curr 0.21 -0.02 - - - -
Book Value 10.60 -1.26 -1.24 -1.36 -1.79 -5.32
Book Value(Adj)-Unit Curr 10.60 -1.26 - - - -

Shareholding Pattern

  • Promoter Group

    10.46%

  • Public Share Holding

    89.54%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 1,212,025 10.46 1,020,625 106
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 1,212,025 10.46 1,020,625 106
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 0 0.00 0 0
2] Non Institution
Bodies Corporate 1,263,585 10.91 1,159,485 50
Clearing Members 0 0.00 0 0
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 262,243 2.26 1,543 301
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 81,133 0.70 81,133 29
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 6,918,669 59.73 6,568,669 41
Individuals holding nominal share capital up to Rs. 1 lakh 1,845,175 15.93 1,000,345 6,460
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 100 0.00 100 1
Others 0 0.00 0 0
Sub Total 10,370,905 89.54 8,811,275 6,882
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 11,582,930 100.00 9,831,900 6,988

Company Background

Venmax Drugs & Pharmaceuticals LtdTrading

  • Venmax Drugs & Pharmaceuticals Ltd
  • BSE Code : 6161.0
  • ISIN : INE154G01022

  • Incorporation Year

    1988

  • Registered Office

    Sy No 115 Brig Sayeed Road
    Hanumanji Colony Old Bowenpall, Secunderabad,
    Telangana-500009

  • Telephone

  • FAX

  • Chairman

  • Managing Director

    Sadhanala Venkata Rao

  • Company Secretary

    Priyanka Agarwal

  • Auditor

    PPKG & Co

  • Face Value

    10

  • Listing

    BSE

  • Registrar

    CIL Securities Limited
    214 RaghavaRatna Tow,
    Chiragali Lane,Abids
    Mumbai - Hyderabad 500001

Venmax Drugs & Pharmaceuticals Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Venmax Drugs 14.48 8.19 8.02 76.21 2.28
Abbott India 25,004.30 7,217.19 6,929.05 32.91 43.78
Astrazeneca Phar 5,988.15 2,304.07 2,275.58 88.26 27.86
Glaxosmi. Pharma 2,404.80 3,932.76 3,790.20 38.42 58.17
Novartis India 1,834.75 393.10 354.33 46.33 15.94
Cipla 1,337.00 20,102.60 18,979.95 35.14 13.88
Bliss GVS Pharma 628.50 773.53 729.81 58.41 12.51
Amrutanjan Healt 487.65 520.13 502.55 26.12 24.16
Fermenta Biotec. 454.90 474.15 450.25 21.24 18.77
Guj. Themis Bio. 327.25 168.25 165.82 87.50 18.05
Ambalal Sarabhai 34.60 19.52 3.94 64.07 6.77